{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "0003-4040",
      "generic_name": "repotrectinib",
      "labeler_name": "E.R. Squibb & Sons, L.L.C.",
      "brand_name": "Augtyro",
      "active_ingredients": [
        {
          "name": "REPOTRECTINIB",
          "strength": "40 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "0003-4040-12",
          "description": "120 CAPSULE in 1 BOTTLE (0003-4040-12)",
          "marketing_start_date": "20231205",
          "sample": false
        },
        {
          "package_ndc": "0003-4040-60",
          "description": "60 CAPSULE in 1 BOTTLE (0003-4040-60)",
          "marketing_start_date": "20231205",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "E.R. Squibb & Sons, L.L.C."
        ],
        "rxcui": [
          "2670649",
          "2670655",
          "2696876",
          "2696878"
        ],
        "spl_set_id": [
          "fb526827-40ba-4462-94cf-179ae3b0cb8a"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0300000000001"
        ],
        "nui": [
          "N0000175605",
          "N0000194093",
          "N0000194094",
          "N0000194095",
          "N0000194096",
          "N0000185506"
        ],
        "pharm_class_epc": [
          "Kinase Inhibitor [EPC]"
        ],
        "pharm_class_moa": [
          "Proto-Oncogene Tyrosine-Protein Kinase ROS1 Inhibitors [MoA]",
          "Tropomyosin Receptor Tyrosine Kinase A Inhibitors [MoA]",
          "Tropomyosin Receptor Tyrosine Kinase B Inhibitors [MoA]",
          "Tropomyosin Receptor Tyrosine Kinase C Inhibitors [MoA]",
          "Cytochrome P450 3A4 Inducers [MoA]"
        ],
        "unii": [
          "08O3FQ4UNP"
        ]
      },
      "marketing_category": "NDA",
      "dosage_form": "CAPSULE",
      "spl_id": "9fa5a47f-24bf-464a-aed7-54ad81abf121",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20231205",
      "product_id": "0003-4040_9fa5a47f-24bf-464a-aed7-54ad81abf121",
      "application_number": "NDA218213",
      "brand_name_base": "Augtyro",
      "pharm_class": [
        "Cytochrome P450 3A4 Inducers [MoA]",
        "Kinase Inhibitor [EPC]",
        "Proto-Oncogene Tyrosine-Protein Kinase ROS1 Inhibitors [MoA]",
        "Tropomyosin Receptor Tyrosine Kinase A Inhibitors [MoA]",
        "Tropomyosin Receptor Tyrosine Kinase B Inhibitors [MoA]",
        "Tropomyosin Receptor Tyrosine Kinase C Inhibitors [MoA]"
      ]
    }
  ]
}